Population health interventions to improve colorectal cancer screening by fecal immunochemical tests: A systematic review

被引:77
|
作者
Issaka, Rachel B. [1 ,2 ,3 ,4 ]
Avila, Patrick [5 ]
Whitaker, Evans [6 ]
Bent, Stephen [7 ]
Somsouk, Ma [8 ]
机构
[1] Fred Hutchinson Canc Res Ctr, Div Clin Res, 1124 Columbia St, Seattle, WA 98104 USA
[2] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, 1124 Columbia St, Seattle, WA 98104 USA
[3] Fred Hutchinson Canc Res Ctr, Hutchinson Inst Canc Outcomes Res, 1124 Columbia St, Seattle, WA 98104 USA
[4] Univ Washington, Sch Med, Div Gastroenterol, Seattle, WA USA
[5] Univ Calif San Francisco, Div Gastroenterol, San Francisco, CA 94143 USA
[6] Univ Calif San Francisco, Med Lib, San Francisco, CA 94143 USA
[7] Univ Calif San Francisco, Dept Med, San Francisco, CA USA
[8] Univ Calif San Francisco, Ctr Vulnerable Populat, San Francisco, CA 94143 USA
基金
美国国家卫生研究院;
关键词
Colorectal cancer; Screening; Fecal immunochemical test; Interventions; Population management; Electronic health records; Systematic review; RANDOMIZED CONTROLLED-TRIAL; BLOOD-TESTS; ADHERENCE; COLONOSCOPY; OUTREACH; FIT; NOTIFICATION; PROGRAM; RATES; CARE;
D O I
10.1016/j.ypmed.2018.10.021
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Despite clear evidence that colorectal cancer (CRC) screening reduces mortality, screening, including fecal immunochemical tests (FIT), is underutilized. We conducted a systematic review to determine the evidence of efficacy of interventions to improve FIT completion that could be scaled and utilized in population health management. We systematically searched publication databases for studies evaluating provider-or system-level interventions to improve CRC screening by FIT between 1 January 1996 and 13 December 2017 without language restrictions. Twenty articles describing 25 studies were included, 23 were randomized controlled trials with 1 quasi-experimental and 1 observational study. Ten studies discussed mailed FIT outreach, 4 pre-FIT patient reminders, 3 tailored patient messages, 2 post-FIT reminders, 2 paired FIT with influenza vaccinations, 2 provider alerts and 1 study each described the use of high-quality small media and patient financial incentives. Mailed FIT outreach was consistently effective with median improvement in CRC screening of 21.5% (inter-quartile range (IQR) 13.6%-29.0%). FIT paired with vaccinations led to a median 15.9% (IQR 15.6%-16.3%) improvement, while pre-FIT and post-FIT reminders demonstrated modest efficacy with median 4.1% (IQR 3.6%-6.7%) and 3.1% (IQR 2.9%-3.3%) improvement in CRC screening, respectively. More than half the studies were at high or unclear risk of bias; heterogeneous study designs and characteristics precluded meta-analysis. FIT-based CRC screening programs utilizing multilevel interventions (e.g. mailed FIT outreach, FIT paired with other preventative services, and provider alerts) have the potential to significantly increase screening participation. However, such programs must also follow-up patients with abnormal FIT results.
引用
收藏
页码:113 / 121
页数:9
相关论文
共 50 条
  • [21] Fecal Immunochemical Tests for Colorectal Cancer Screening: Is Fecal Sampling from Multiple Sites Necessary?
    Amitay, Efrat L.
    Gies, Anton
    Weigl, Korbinian
    Brenner, Hermann
    [J]. CANCERS, 2019, 11 (03):
  • [22] GUAIAC AND IMMUNOCHEMICAL TESTS FOR FECAL OCCULT BLOOD IN COLORECTAL-CANCER SCREENING
    CASTIGLIONE, G
    GRAZZINI, G
    CIATTO, S
    [J]. BRITISH JOURNAL OF CANCER, 1992, 65 (06) : 942 - 944
  • [23] Reducing Rejected Fecal Immunochemical Tests Received in the Laboratory for Colorectal Cancer Screening
    Cheng, Caleb
    Ganz, David A.
    Chang, Evelyn T.
    Huynh, Alexis
    De Peralta, Shelly
    [J]. JOURNAL FOR HEALTHCARE QUALITY, 2019, 41 (02) : 75 - 82
  • [24] Compliance with fecal immunochemical tests for colorectal cancer screening: A prospective cohort study
    Ching, Jessica Y. L.
    Wong, Martin C. S.
    Tsoi, Kelvin K. F.
    Lam, Thomas Y. T.
    Luk, Arthur K. C.
    Hirai, Hoyee W.
    Griffiths, Sian M.
    Chan, Francis K. L.
    Sung, Joseph J. Y.
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2012, 27 : 197 - 197
  • [25] Risk-Adapted Cutoffs in Colorectal Cancer Screening by Fecal Immunochemical Tests
    Peng, Le
    Balavarca, Yesilda
    Niedermaier, Tobias
    Weigl, Korbinian
    Hoffmeister, Michael
    Brenner, Hermann
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 (07): : 1110 - 1116
  • [26] Interventions to increase uptake of faecal tests for colorectal cancer screening: a systematic review
    Rat, Cedric
    Latour, Chloe
    Rousseau, Rosalie
    Gaultier, Aurelie
    Pogu, Corinne
    Edwards, Adrian
    Nguyen, Jean-Michel
    [J]. EUROPEAN JOURNAL OF CANCER PREVENTION, 2018, 27 (03) : 227 - 236
  • [27] A systematic review of interventions to improve breast cancer screening health behaviours
    Acharya, Amish
    Sounderajah, Viknesh
    Ashrafian, Hutan
    Darzi, Ara
    Judah, Gaby
    [J]. PREVENTIVE MEDICINE, 2021, 153
  • [28] Test Characteristics of Fecal Immunochemical Tests for Colorectal Cancer and Advanced Adenomas Based on Location: A Systematic Review
    Imperiale, Thomas F.
    Roth, Sarah M.
    Imperiale, Nick R.
    Stump, Timothy E.
    Blevins, Amy E.
    Monahan, Patrick O.
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S221 - S222
  • [29] FECAL IMMUNOCHEMICAL TESTS FOR COLORECTAL CANCER SCREENING HOW ADENOMA CHARACTERISTICS IMPACT TEST SENSITIVITY: A SYSTEMATIC REVIEW AND META-ANALYSIS
    Todorovic, Jovan
    Jahn, Beate
    Mladenovic, Marija
    Sroczynski, Gaby
    Rochau, Ursula
    Puntscher, Sibylle
    Santamaria, Julia
    Allende, Valentino
    Oefner, Dietmar
    Ferlitsch, Monika
    Haider, Karin
    Greuter, Marjolein J. E.
    Coupe, Veerle M. H.
    Stojnev, Slavica
    Siebert, Uwe
    [J]. MEDICAL DECISION MAKING, 2021, 41 (04) : E171 - E173
  • [30] Cost analysis review of a patient navigator and fecal immunochemical testing on colorectal cancer screening in an underserved population
    Hannah W. Fiske
    Joao Filipe G. Monteiro
    Ross W. Hilliard
    Ricky Grisson
    Marlaydis Holloway
    Carrie Bridges Feliz
    Harlan Rich
    [J]. Discover Health Systems, 3 (1):